About My Health Careers Internship MedBlogs Contact us

New, Promising Drug Helps Prevent Head and Neck Cancers

by Sheela Philomena on April 12, 2013 at 12:09 PM
Font : A-A+

 New, Promising Drug Helps Prevent Head and Neck Cancers

Researchers at Fox Chase Cancer Center have moved a step closer to the goal of prevention of head and neck cancers. Head and neck cancers typically begin in squamous cells that line moist surfaces inside the mouth, nose and throat. Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most common type of cancer in the United States, and it is sometimes preceded by the appearance of changes inside the oral cavity called precancerous lesions. The most common type of change is a white patch known as a leukoplakia. Because it often takes decades for leukoplakias to develop into HNSCC, there is a window of opportunity to recognize and revert precancerous changes, thus preventing this type of cancer.

They found that pharmacological inhibition of this gene, called cytochrome P450 1B1 (CYP1B1), led to a decrease in the movement and proliferation of leukoplakia cells. This research, was carried out by Ekaterina G. Shatalova, PhD, Research Associate at Fox Chase, and Margie L. Clapper, PhD, Co-leader of the Cancer Prevention and Control Program at Fox Chase.


"The difficulty in treating head and neck cancer is that the majority of the patients are diagnosed at advanced stages. This is one of the reasons why the five-year survival rate for head and neck cancer is only 40 to 50 percent," says Dr. Shatalova. "So the earlier we can treat these patients, the better."

The CYP1B1 protein metabolizes tobacco smoke and ethanol, known risk factors for head and neck cancer, generating potentially carcinogenic compounds. Shatalova, Clapper and their colleagues previously found that genetic deletion of CYP1B1 dramatically reduced the migration and proliferation of leukoplakia cells taken from the mouths of patients. "In the present study, we wanted to see if treating the same cells with a pharmacologic CYP1B1 inhibitor, which could possibly be used in humans, would have the same effect on cell motility and proliferation as genetic manipulation," Shatalova says.

In the new study, the researchers used homoeriodictyol (HED), a common dietary flavonoid that selectively inhibits CYP1B1. Consistent with their previous findings, exposure of leukoplakia cells to HED for several days resulted in an approximate seven-fold decrease in the rate of cell movement, as well as a 33 percent decrease in proliferation, when compared with untreated cells.

"Because the compound we used is abundant in citrus fruits and it is considered by the Food and Drug Administration to be a safe food additive, it is likely to be non-toxic to humans and thus could represent a promising agent for routine use," Shatalova says.

Moving forward, the researchers will test whether HED treatment reduces tumor growth and metastasis in animal models. "These novel effects of CYP1B1 inhibition could guide efforts to establish new strategies for the prevention and treatment of head and neck cancers," Shatalova says.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Memory Loss - Can it be Recovered?
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Cancer Head and Neck Cancers 

Recommended Reading
Zalutumumab Prolongs Survival of Patients With Incurable Head and Neck Cancer
Head & Neck Cancer of squamous type that no longer responding to chemotherapy may respond to ......
Alterations in Head and Neck Cancer That Could Lead to Targeted Therapy Identified by Comprehensive Genomic Analysis
Head and neck cancers with certain distinctive patterns could be amenable to specific targeted ......
New Drug Combo Could Prevent Head and Neck Cancer in High-Risk Patients
A recent study reveals a new drug combination that holds promise in reducing the risk for patients ....
Safety-Net Hospitals: Surgical Outcomes After Head and Neck Cancer Examined
A report says that safety-net hospitals appear to provide head and neck cancer surgical care to a .....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Head and Neck Cancers
Head and neck cancers usually occur in the squamous cells lining the moist, mucosal surfaces inside ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use